Drawing for TARSUS

USPTO serial 99562062

TARSUS

Reviewed by CopyMark Law Group

Status 661
Filing date
Status date
Registration date
—
Examiner
STEINPFAD, SARAH E
Law office
TMO LAW OFFICE 120

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TARSUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Catherine J. Holland

Catherine J. Holland KNOBBE, MARTENS, OLSON & BEAR, LLP2040 Main Street, 14th FloorIrvine, CA 92614United States

Goods and services

ClassDescriptionStatusFirst use
005Ophthalmic preparations; Preparations for destroying parasites; Pharmaceutical preparations for the treatment of Demodex blepharitis; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Eye drops; Pharmaceutical preparations for the treatment of eye diseases and conditionsACTIVEMar 4, 2021
042Pharmaceutical research and development; Providing medical and scientific research information; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing information about medical and scientific research via a websiteACTIVEAug 8, 2018
044Providing medical information; Providing medical information in the field of ophthalmic diseases; Providing medical information in the field of treatments for ophthalmic diseases; Providing medical information in the field of Demodex blepharitis; Providing a web site featuring medical information; Providing a website featuring information in the field of the diagnosis and treatment of Demodex blepharitisACTIVEAug 8, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 2, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 2, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 2, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 30, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jul 30, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
May 27, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 27, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 27, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 1, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 1, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 1, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 24, 2026DOCKASSIGNED TO EXAMINER—
Dec 22, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 22, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 22, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance